Dr. Amy K. Krie, MD
- Medicare services, 2024
- 439
- Medicare patients, 2024
- 201
- Part D claims, 2024
- 1,296
- Publications
- 11
- Clinical trials
- 19
- Practice address
- 800 East 28th Street, Minneapolis, MN 55407
- Practice phone
- Call (612) 863-4000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Krie's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Amy K. Krie is a medical oncologist in Minneapolis, Minnesota
Dr. Krie practices at Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health.
Dr. Krie's NPI, 1083648075, was assigned on July 10, 2006. Dr. Krie graduated from Carver College of Medicine in 2001. Dr. Krie holds South Dakota license 5837.
- NPI
- 1083648075NPI Registry (opens in a new tab)
- Medicare PAC ID
- 3779539705
- NPI enumeration date
- July 10, 2006
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (612) 863-4000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 51
- Medical school graduation
- 2001
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Amy K. Krie practices at Abbott Northwestern Hospital in Minneapolis, Minnesota
Dr. Krie's primary practice is Abbott Northwestern Hospital, at 800 East 28th Street, Minneapolis, MN 55407 in Hennepin County. The practice phone is (612) 863-4000.
- Abbott Northwestern Hospital800 East 28th Street, Minneapolis, MN 55407 · Hennepin CountyPhone(612) 863-4000
Source: Dmand AI Affiliation Data
Dr. Amy K. Krie is affiliated with 3 sites of care and 1 medical group
Dr. Krie's primary practice is Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health. Dr. Krie is also affiliated with Mercy Hospital. The medical group on file is Buffalo Hospital. Dmand AI also links Dr. Krie to 1 more home health agency, named with a free account.
Sources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Amy K. Krie's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Krie practices, 3 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| Abbott Northwestern Hospital | Available with a free account |
| +2 more affiliated sites | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
Dmand AI maps EHR vendors, IT decision makers and buying committees across Sutter Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Amy K. Krie is one of 122 medical oncologists in Minnesota
Medical oncology is Dr. Krie's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Krie is board certified in medical oncology by the American Board of Internal Medicine. Dmand AI has Dr. Krie's licenses on file in 4 states: South Dakota, Oregon, Minnesota and Iowa.
Specialties and state licenses
- Medical oncology, South DakotaPrimary
- Oregon license
- Minnesota license
- Iowa license
Clinical focus
Dmand AI lists breast cancer among the conditions Dr. Krie treats.
Medical oncologists near Dr. Krie
Counts of medical oncologists with a Dmand AI profile, by place and practice. Each opens the list.
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Amy K. Krie billed Medicare for 439 services in 2024
CMS data shows 439 Medicare services from Dr. Krie across 6 procedure codes in 2024, for 201 Medicare patients. Medicare paid $27,306 for them.
Dr. Krie's Medicare services by type, 2023 to 2024
- 2023
- 2024
- Office and hospital visits
- 2023: 3362024: 3525%
- Other services
- 2023: 02024: 87
Where Dr. Krie's Medicare services took place, 2024
- In an office10123%
- In a facility33877%
Dr. Krie compared with the Minnesota median for medical oncologists, 2024
- Dr. Krie
- Minnesota median
- Medicare services
- 439vs 1,28466% below
- Medicare patients
- 201vs 24819% below
- Part D claims
- 1,175vs 1966.0 times
Medians across 119 medical oncologists in Minnesota with Dmand AI profiles that report each measure.
Dr. Krie's most billed Medicare procedure codes, 2024
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Krie?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Krie and other medical oncologists in Minnesota.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Amy K. Krie treated 201 Medicare patients in 2024, average age 74
CMS counts 201 Medicare patients who saw Dr. Krie in 2024. The largest group is 65 to 74, with 112 patients. 75% of them have cancer, and 60% have high cholesterol. Their average risk score is 1.03, where 1.00 is the Medicare average.
Across all payers, Dmand AI patient panel data puts Dr. Krie's median patient age at 65, with 99% women.
Dr. Krie's Medicare patients by age, 2024
CMS leaves out age groups with fewer than 11 patients.
Chronic conditions among Dr. Krie's Medicare patients, 2024
- Cancer75%
- High cholesterol60%
- High blood pressure54%
- Arthritis40%
- Mood disorders30%
- Osteoporosis29%
- Depression27%
- Anxiety25%
Share of Medicare patients with each condition. A patient can have several.
Dr. Krie's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 65
Patient panel by sex, all payers
- Women99%
- Men1%
Sources: Dmand AI Patient Panel Data; and Medicare Physician & Other Practitioners - by Provider (CMS), 2024 data
Dr. Amy K. Krie wrote 1,296 Medicare Part D claims in 2024
In 2024, Dr. Krie wrote 1,296 Medicare Part D claims for 388 patients. 94% of them were for generic drugs. CMS names the drug for 1,175 of them, across 14 drugs with 11 or more claims each, at $559,512 in total drug cost. In 2023, CMS named 1,001 claims across 11 drugs.
Dr. Krie's Part D claims by kind of drug, 2024
- Generic1,224 claims94%
- Brand-name72 claims6%
Dr. Krie's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Drug classes CMS tracks in Dr. Krie's Part D claims, 2024
- Antibiotics1%14 of 1,296 claims
- Antipsychotics, patients 65 and over1%12 of 1,296 claims
Share of all Part D claims for each drug class CMS reports on. Classes with no claims are left out.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1,0012024: 1,17517%
Drugs named by CMS: 14 in 2024, 11 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Amy K. Krie offers telehealth to Medicare patients
Dr. Krie accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Krie as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Amy K. Krie has 11 publications on record
Dmand AI links 11 papers to Dr. Krie, published from 2017 to 2024. 2017 was the busiest year, with 2. The most frequent topics are Breast Neoplasms, Antineoplastic Agents, Hormonal and Biomarkers, Tumor. Dr. Krie's most frequent co-authors are Marc E. Boisvert, MD, Paul Timothy Fanta, MD and Armando E. Giuliano, FACS, MD.
Dr. Krie's papers by year, 2017 to 2024
Topics Dr. Krie writes about most
- Breast Neoplasms
- Antineoplastic Agents, Hormonal
- Biomarkers, Tumor
- Carcinoma, Intraductal, Noninfiltrating
- Receptor, ErbB-2
- Watchful Waiting
Dr. Krie's most frequent co-authors
- Marc E. Boisvert, MD2 shared papers
- Paul Timothy Fanta, MD2 shared papers
- Armando E. Giuliano, FACS, MD2 shared papers
Recent publications by Dr. Krie
Cold Spring Harb Mol Case Stud
See who Dr. Krie researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Krie works with, so you can find a warm path to the right medical oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Amy K. Krie has worked on 19 clinical trials
Dmand AI links Dr. Krie to 19 clinical trials, 9 of them phase 3 studies. 13 are still active or recruiting. Conditions studied include Breast Neoplasms, Breast Diseases and Breast Neoplasms, Male. National Cancer Institute (NCI) sponsors the most, 9. Open Payments lists research payments to Dr. Krie that name 1 trial.
Clinical trials with Dr. Krie by phase
- NonePhase 1: no trials
- 5Phase 2: 5 trials
- 1Phase 2/3: 1 trial
- 9Phase 3: 9 trials
- NonePhase 4: no trials
Conditions in Dr. Krie's trials
- Breast Neoplasms
- Breast Diseases
- Breast Neoplasms, Male
- Carcinoma, Non-Small-Cell Lung
- Carcinoma, Bronchogenic
Investigators on the most trials with Dr. Krie
- Terrence P. Cescon, MD8 shared trials
- James Mitchell Granfortuna, MD8 shared trials
- Mark F. Kozloff, MD8 shared trials
Recent clinical trials with Dr. Krie
A Study of Tucatinib Plus Trastuzumab Deruxtecan in HER2+ Breast Cancer (opens in a new tab)
Testing MK-3475 (Pembrolizumab) as Adjuvant Therapy for Triple Receptor-Negative Breast Cancer (opens in a new tab)
FOLFIRI or Modified FOLFIRI and Veliparib as Second Line Therapy in Treating Patients With Metastatic Pancreatic Cancer (opens in a new tab)
Lung-MAP: Nivolumab With or Without Ipilimumab as Second-Line Therapy in Treating Patients With Recurrent Stage IV Squamous Cell Lung Cancer and No Matching Biomarkers (opens in a new tab)
Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma (opens in a new tab)
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Amy K. Krie received $894,998 in industry payments from 2017 to 2025
CMS Open Payments shows 832 general payments to Dr. Krie from 8 drug and device companies from 2017 to 2025. Speaker and faculty fees make up the largest share, 75% of the total. AstraZeneca Pharmaceuticals LP paid the most, $387,278. It also lists 2 research payments totaling $4,299 from 2023 to 2024, naming 1 clinical trial.
General payments to Dr. Krie by program year, 2017 to 2025
General payments to Dr. Krie by kind, 2017 to 2025
- Speaker and faculty fees$673,36175%
- Travel and lodging$120,64113%
- Consulting fees$90,11910%
- Food and beverage$10,1741%
- Other$7020%
Companies that paid Dr. Krie the most, 2017 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Dr. Amy K. Krie has 2 awards and honors on record
Dmand AI lists 2 awards for Dr. Krie, most recently CMS Stage 1 EHR in 2012.
Awards and honors for Dr. Krie
- 2012
- CMS Stage 1 EHR
- Undated
- Compassionate Doctors
Source: Dmand AI Professional Profile Data
Dr. Amy K. Krie graduated from Carver College of Medicine
Dr. Krie graduated from Carver College of Medicine in 2001.
- Medical school
- Board certified in medical oncology
Source: Dmand AI Professional Profile Data
Dr. Amy K. Krie accepts plans from 15 insurance carriers
Dr. Krie is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
- Aetna
- Elevance
- United Healthcare
- Blue Cross Blue Shield of Michigan
- Medica
- HCSC
- Blue Cross Blue Shield of Massachusetts
- Regence Health Plans
- +7 more carriersWith a free account
Plan types Dr. Krie accepts, by number of carriers
- PPO10
- Medicare9
- HMO7
- POS5
- EPO4
- Medicaid2
Source: Dmand AI Insurance Network Data
Sources for Dr. Amy K. Krie's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel DataMedicare Physician & Other Practitioners - by Provider (CMS) (opens in a new tab) |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| Awards and committee roles | Dmand AI Professional Profile Data |
| Training, board certification and memberships | Dmand AI Professional Profile Data |
| Insurance carriers and plan types | Dmand AI Insurance Network Data |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Amy K. Krie
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Amy K. Krie's NPI number?
Dr. Amy K. Krie's NPI number is 1083648075. It was assigned on July 10, 2006, and it is active in the NPI Registry.
What kind of doctor is Dr. Amy K. Krie?
Dr. Amy K. Krie is a medical oncologist in Minneapolis, Minnesota. The primary specialty in the NPI Registry is Medical Oncology Physician (taxonomy code 207RX0202X).
Where does Dr. Amy K. Krie practice?
Dr. Krie practices at 800 East 28th Street, Minneapolis, MN 55407. Dr. Krie's primary practice is Abbott Northwestern Hospital in Minneapolis, Minnesota, part of Sutter Health. Dmand AI also links Dr. Krie to 1 home health agency.
What is Dr. Amy K. Krie's office phone number?
The practice phone on file for Dr. Krie is (612) 863-4000.
What is Dr. Amy K. Krie's medical license number?
Dr. Krie holds South Dakota license 5837, one of the licenses on file in 4 states.
Which states has Dr. Amy K. Krie been licensed in?
Dmand AI has state licenses on file for Dr. Krie in South Dakota (since 2021), Oregon (since 2003), Minnesota (2020 to 2026) and Iowa (2004 to 2022).
Which hospitals is Dr. Amy K. Krie affiliated with?
Dr. Krie practices at Abbott Northwestern Hospital in Minneapolis, Minnesota. Dr. Krie is also affiliated with Mercy Hospital.
What medical group is Dr. Amy K. Krie part of?
Dr. Krie is linked to Buffalo Hospital.
Does Dr. Amy K. Krie accept Medicare?
Yes. CMS data shows Dr. Krie billed Medicare for 439 services in 2024, and Dr. Krie accepts Medicare assignment.
Does Dr. Amy K. Krie offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Krie as offering telehealth services.
Show 10 more questionsShow fewer questions
How many Medicare patients does Dr. Amy K. Krie see?
CMS counts 201 Medicare patients who saw Dr. Krie in 2024, with an average age of 74.
Is Dr. Amy K. Krie board certified?
Yes. Dr. Krie is board certified in medical oncology by the American Board of Internal Medicine.
What services does Dr. Amy K. Krie bill to Medicare?
In 2024, Dr. Krie's most billed Medicare services were office visit, established patient (99214), medicare service (G2211) and office visit, established patient (99215).
Where did Dr. Amy K. Krie go to medical school?
Dr. Krie graduated from Carver College of Medicine in 2001.
What drugs does Dr. Amy K. Krie prescribe most?
In 2024 Medicare Part D data, Dr. Krie's most prescribed drugs by claims were Anastrozole, Letrozole and Tamoxifen Citrate.
Has Dr. Amy K. Krie received payments from drug or device companies?
CMS Open Payments shows $894,998 in general payments to Dr. Krie from 8 companies from 2017 to 2025. The largest total came from AstraZeneca Pharmaceuticals LP.
How long has Dr. Amy K. Krie been practicing?
Dr. Krie graduated from medical school in 2001, 25 years ago.
Does Dr. Amy K. Krie do research?
Dmand AI links 11 publications to Dr. Krie, published from 2017 to 2024. Dr. Krie has worked on 19 clinical trials.
Who does Dr. Amy K. Krie publish with?
Dr. Krie's most frequent co-authors are Marc E. Boisvert, MD (2 shared papers), Paul Timothy Fanta, MD (2 shared papers) and Armando E. Giuliano, FACS, MD (2 shared papers).
What insurance does Dr. Amy K. Krie accept?
Dr. Krie is in network with 15 carriers, including Aetna, Elevance and United Healthcare. PPO plans come from the most carriers, 10. Check the plan with the practice before a visit.
Selling to medical oncology practices?
See medical oncologists in Minnesota by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card